Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 7 results

Author Title Type [ Year

]

Filters: Author is Berry, Andrea A [Clear All Filters]

2019

Laurens, Matthew B, Andrea A Berry, Mark A Travassos, Kathy Strauss, Matthew Adams, Biraj Shrestha, Tao Li, et al.. 2019. “Dose-Dependent Infectivity Of Aseptic, Purified, Cryopreserved Plasmodium Falciparum 7G8 Sporozoites In Malaria-Naive Adults.”. J Infect Dis 220 (12). J Infect Dis: 1962-1966. doi:10.1093/infdis/jiz410.

Munoz, Flor M, Evan J Anderson, David I Bernstein, Christopher J Harrison, Barbara Pahud, Edwin Anderson, Buddy C Creech, et al.. 2019. “Safety And Immunogenicity Of Unadjuvanted Subvirion Monovalent Inactivated Influenza H3N2 Variant (H3N2V) Vaccine In Children And Adolescents.”. Vaccine 37 (36). Vaccine: 5161-5170. doi:10.1016/j.vaccine.2019.07.085.

2018

Widdice, Lea E, Elizabeth R Unger, Gitika Panicker, Rebecca Hoagland, Todd S Callahan, Lisa A Jackson, Andrea A Berry, et al.. 2018. “Antibody Responses Among Adolescent Females Receiving Two Or Three Quadrivalent Human Papillomavirus Vaccine Doses At Standard And Prolonged Intervals.”. Vaccine 36 (6). Vaccine: 881-889. doi:10.1016/j.vaccine.2017.12.042.

Widdice, Lea E, Rebecca Hoagland, Todd S Callahan, Jessica A Kahn, Christopher J Harrison, Barbara A Pahud, Sharon E Frey, et al.. 2018. “Caregiver And Adolescent Factors Associated With Delayed Completion Of The Three-Dose Human Papillomavirus Vaccination Series.”. Vaccine 36 (11). Vaccine: 1491-1499. doi:10.1016/j.vaccine.2017.12.060.

2016

Libster, Romina, Monica McNeal, Emmanuel B Walter, Andi L Shane, Patricia Winokur, Gretchen Cress, Andrea A Berry, et al.. 2016. “Safety And Immunogenicity Of Sequential Rotavirus Vaccine Schedules.”. Pediatrics 137 (2). Pediatrics: e20152603. doi:10.1542/peds.2015-2603.

2015

Jackson, Lisa A, James D Campbell, Sharon E Frey, Kathryn M Edwards, Wendy A Keitel, Karen L Kotloff, Andrea A Berry, et al.. 2015. “Effect Of Varying Doses Of A Monovalent H7N9 Influenza Vaccine With And Without As03 And Mf59 Adjuvants On Immune Response: A Randomized Clinical Trial.”. Jama 314 (3). Jama: 237-46. doi:10.1001/jama.2015.7916.

Halasa, Natasha B, Michael A Gerber, Andrea A Berry, Edwin L Anderson, Patricia Winokur, Harry Keyserling, Allison Ross Eckard, et al.. 2015. “Safety And Immunogenicity Of Full-Dose Trivalent Inactivated Influenza Vaccine (Tiv) Compared With Half-Dose Tiv Administered To Children 6 Through 35 Months Of Age.”. J Pediatric Infect Dis Soc 4 (3). J Pediatric Infect Dis Soc: 214-24. doi:10.1093/jpids/piu061.